The dynamics of the cancer cachexia market is expected to gain momentum as several companies are testing the waters, advancing cancer cachexia pipeline.
More than half of the cancer patients suffer from cachexia, and over 30% of the cancer patients succumb to death due to complications that arise from cachexia. Cachexia is a complex metabolic syndrome, which is characterized by the loss of fat and muscles in the body. Cachexia is observed as a result of underlying diseases, including cancer, AIDS, tuberculosis, chronic heart failure, hormonal deficiency, and others.
Cachexia results in a loss of atleast 5% of the bodyweight loss, and adipose tissue wast...
